Skip to main content

Table 1 Demographic characteristics and outcomes of two groups

From: A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India

Characteristic PQ high dose (N = 25) n (%) or Mean ± SD PQ low dose (N = 25) n (%) or Mean ± SD p-value
Gender
 Male 23 (92) 22 (88) 0.63
 Female 2 (8) 3 (12)  
Age, years 42.0 ± 16.0 40.0 ± 15.0 0.34
Body weight, kg 67.9 ± 14.1 64.6 ± 13.7 0.40
Body mass index, kg/m2 25.0 ± 4.0 24.6 ± 5.2 0.43
Past h/o malaria 6 (24) 11 (44) 0.13
Pre-morbidities
 Diabetes mellitus 2 (8) 4 (16) 0.38
 Hypertension 2 (8) 5 (20) 0.22
 Chronic kidney disease 0 1 (4) 0.31
 Heart disease 0 2 (8) 0.15
Severity
 Non-severe 24 (96) 24 (96) 1.00
 Severe 1 (4) 1 (4)  
Schizonticidal treatment
 Chloroquine 20 (80) 19 (76) 0.73
 Artemisinin combination therapy 5 (20) 6 (24)  
Use of personal protective measures during follow-up
 Mosquito repellents 16 (64) 18 (72) 0.54
 Regular bed net 3 (12) 2 (8) 0.63
Study outcome
 Recurrence 2 (4) 2 (4)